NCT05221333View on ClinicalTrials.gov

Sorrel 25R Injector - Sorrel Clinical Study Protocol

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

December 15, 2022

Study Completion Date

December 30, 2022

Conditions
Injection SiteInjection Site ReactionInjection Site Irritation
Interventions
DEVICE

Sorrel Wearable Injector

Use of Sorrel Wearable Injector in pilot study

Trial Locations (1)

19107

RECRUITING

Thomas Jefferson University Hospital, Philadelphia

Sponsors

Lead Sponsor

Eitan Medical
All Listed Sponsors
collaborator

Thomas Jefferson University

OTHER

lead

Eitan Medical

INDUSTRY